Safety and Efficacy of Transition From Subcutaneous Treprostinil to Oral Sildenafil in Patients With Pulmonary Arterial Hypertension

Journal of Heart and Lung Transplantation

Volumn 26, Issue 11, 2007, Pages 1079-1083

  Keogh, Anne M ^a   Jabbour, Andrew ^a   Weintraub, Robert ^b   Brown, Karen ^a   Hayward, Chris S ^a   Macdonald, Peter S ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; SILDENAFIL; UNIPROST; WARFARIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEMOGRAPHY; DIARRHEA; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEADACHE; HEART VENTRICLE SEPTUM DEFECT; HUMAN; INJECTION SITE PAIN; LIVER FUNCTION; MALE; MONOTHERAPY; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; SCLERODERMA; SIDE EFFECT; STATISTICAL ANALYSIS; THROMBOEMBOLISM; TREATMENT DURATION; VISUAL DISORDER;

ADMINISTRATION, ORAL; ADULT; ANTIHYPERTENSIVE AGENTS; DRUG TOXICITY; EPOPROSTENOL; EXERCISE TOLERANCE; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; PIPERAZINES; PURINES; QUALITY OF LIFE; SULFONES; VASODILATOR AGENTS;

EID: 36048998787     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.07.040     Document Type: Article

References (15)

1. Corbin J.P., and Francis S.H. Cyclic GMP phosphodiesterase 5. Target of sildenafil. J Biol Chem 274 (1999) 13729-13732
2. Atz A.M., and Wesser D.L. Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anaesthesiology 91 (1999) 307-310
3. Wilkens W., Guth A., Konig J., et al. Effect of inhaled iloprost plus sildenafil in patients with primary pulmonary hypertension. Circulation 104 (2001) 1218-1222
4. Ghofrani H.A., Wiedemann R., Rose F., et al. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med 136 (2002) 515-522
5. Kulkarni A., Singh P., Sarnaik A., et al. Sildenafil for pulmonary hypertension after heart transplantation. J Heart Lung Transplant 23 (2004) 1441-1444
6. Jabbour A., Keogh A.M., Hayward C.S., et al. Chronic sildenafil lowers transpulmonary gradient and improves cardiac output allowing successful heart transplantation. Eur J Heart Fail 9 (2007) 674-677
7. Mickelakis E., Tymchak W., Lien D., et al. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension. Comparison with inhaled nitric oxide. Circulation 105 (2002) 2395-2400
8. Lepore J.J., Maroo A., Pereira N.L., et al. Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with pulmonary hypertension. Am J Cardiol 90 (2002) 677-680
9. Zhao L., Mason N.A., Morell N.W., et al. Sildenafil inhibits hypoxia-induced pulmonary hypertension. Circulation 104 (2001) 424-428
10. Galie N., Ghofrani H.A., Torbicki A., et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 353 (2005) 2148-2157
11. Rector T.S., and Cohn J.N. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Am Heart J 124 (1992) 1017-1024
12. Sheth A., Park J.E., Ong Y.E., et al. Early haemodynamic benefit of sildenafil in patients with coexisting chronic thromboembolic pulmonary hypertension and left ventricular dysfunction. Vasc Pharmacol 42 (2005) 41-45
13. Ruiz M.J., Escribano P., Delgado J.F., et al. Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experience. J Heart Lung Transplant 25 (2006) 1353-1357
14. McLaughlin V., Sitbon O., Sigman J., et al. Continuous subcutaneous infusion of remodulin, a prostacyclin analogue, in patients with pulmonary artery hypertension; long term outcome. Circulation 104 (2001) 17 II-250
15. Zimmerman A.T., Calvert A.F., and Veitch E.M. Sildenafil improves right ventricular parameters and quality of life in primary pulmonary hypertension. Int Med J 32 (2002) 424-426